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Abstract
Background
Many decisions around vascular access for haemodialysis warrant a collaborative treat-
ment decision-making process, involving both clinician and patient. Yet, patients’ experi-
ences in this regard have been suboptimal. Although clinical practice guidelines could
facilitate collaborative decision making, they often focus on the clinicians’ side of the pro-
cess, while failing to address the patients’ perspective. The objective of this study was to
explore and compare kidney patients’ and clinicians’ views on what vascular access-related
decisions deserved priority for developing guidelines that will contribute to optimizing collab-
orative decision making.
Methods
In the context of updating their vascular access guideline, European Renal Best Practice
surveyed an international panel of 85 kidney patients, 687 nephrologists, 194 nurses, and
140 surgeons/radiologists. In an electronic questionnaire, respondents rated 42 vascular
access-related topics on a 5-point Likert scale. Based on mean standardized ratings, we
compared priority ratings between patients and each clinician group.
Results
Selection of access type and site, as well as prevention of access infections received top
priority across all respondent groups. Patients generally assigned higher priority to
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decisions regarding managing adverse effects of arteriovenous access and patient involve-
ment in care, while clinicians more often prioritized decisions around sustaining patients’
access options, technical aspects of access creation, and optimizing fistula maturation and
patency.
Conclusion
Apart from identifying the most pressing knowledge gaps, our study provides pointers for
developing guidelines that may improve healthcare professionals’ understanding of when to
involve patients along the vascular access pathway.
Introduction
Policy makers encourage collaborative decision making in health care [1–3] aimed at reaching
a mutual agreement between patient and clinician on which treatment to choose, taking into
account the best available evidence, as well as patients’ values and preferences [4].
Many decisions around vascular access for haemodialysis warrant a collaborative decision-
making process. Firstly because numerous aspects of access creation and subsequent mainte-
nance (e.g., selection of access type, infection prevention) may profoundly influence patients’
lifestyle and psychosocial well-being [5], or could benefit from patients’ adherence or self-man-
agement skills[6]. Furthermore, the underlying evidence base for several vascular access-related
choices is weak or flawed. For example, when choosing how to preoperatively assess vessels for
fistula suitability, it is uncertain whether the potential benefits of more invasive tests outweigh
potential harm compared to a clinical examination [7]; and a systematic review found a high
risk of selection bias in studies exploring the association between access type and outcomes [8].
Despite the apparent need for making decisions on vascular access collaboratively, previous
research suggested that patients’ experiences in this regard were suboptimal [5,9]. This poten-
tially leads to patients feeling emotionally unprepared for vascular access [5], perceiving a lack
of choice regarding renal replacement therapy [9], or being reluctant to consider a fistula after
starting haemodialysis on a catheter [10,11]. The suboptimal decision-making process may
partly stem from the lack of support to make collaborative and informed choices around vascu-
lar access. Clinical practice guidelines have been suggested as a starting point to provide such
support [12–14]. However, they often strongly focus on the clinicians’ side of decision making
by only synthesizing the best available evidence, while failing to incorporate the influence of
patients’ preference and their clinical and socio-personal context [15].
European Renal Best Practice (ERBP) produces guidance for health professionals who pro-
vide care to kidney patients in Europe and neighboring regions (www.european-renal-best-
practice.org). Within the context of updating its 2007 vascular access guideline [16], ERBP sur-
veyed an international panel of kidney patients and clinicians about their perspectives on what
decisions related to vascular access care deserved priority for coverage by the updated guide-
line. Exploring and comparing both perspectives will provide pointers for developing guidance
that contributes to optimizing collaborative vascular access decision making.
Methods
The process of identifying and prioritizing all relevant treatment decisions along the vascular
access care pathway (vascular access ‘topics’) comprised three phases (Fig 1). In phase 0, we
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created a preliminary list of topics based on a literature review, and input from a multidisci-
plinary expert group. This group consisted of two kidney patients, two nephrologists, a renal
nurse, two surgeons, and a radiologist. In phase 1, an international panel of clinicians and kid-
ney patients rated the priority of these topics, as well as suggesting additional topics to comple-
ment the preliminary list. The additional topics were prioritized in phase 2.
Developing the questionnaire
We first explored which clinical topics related to permanent vascular access care were
addressed in randomized studies, systematic reviews, meta-analyses by searching the Cochrane
database, combining MeSH terms and keywords related to vascular access, kidney disease, and
dialysis (S1 File). Based on title and abstract, two reviewers (SV and MH) extracted the primary
topic addressed in each study. They also reviewed available English language guidelines [16–
19] for additional topics. Based on the exploratory review, we drafted a topic list, which the
expert group reviewed and complemented; this resulted in a preliminary list of 39 topics,
which respondents prioritized in the phase 1 questionnaire; they could also suggest additional
topics. This generated three new topics (prioritized in phase 2), resulting in a final list of 42
topics; ten referred to general aspects of access care, 25 specifically to fistulas/grafts, and seven
to permanent catheters (see S2 File). While clinicians prioritized all, patients rated only the
general topics, and those referring to the access type with which they had most experience.
Fig 1. Flow chart of process of identifying and prioritizing treatment decisions (i.e., topics) around permanent vascular access
doi:10.1371/journal.pone.0128228.g001
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All participants rated the priority of topics on an unbalanced 5-point Likert scale [20], with
a rating of 1 indicating ‘not important’ and the other four indicating some degree of impor-
tance (ranging from 2 ‘a little important’ to 5 ‘very important’). Patients could indicate that
they were unable to rate a topic's priority, e.g., because they needed more information.
Two sets of cues [21] aimed to align the concept of priority among respondents. Clinicians’
cues focused on prioritizing topics reflecting decisions with considerable impact on patient out-
comes, for which there was insufficient or conflicting evidence on what to do, or that were
prevalent in clinical practice [22]. Cues for patients tried to capture topics for which respon-
dents strongly preferred some treatment options to others while assuming medical equipoise.
All questionnaires were electronic and developed in SurveyMonkey. Questionnaires for cli-
nicians were in English, and pilot-tested by our expert group. Patients received questionnaires
professionally translated from English into their native language, and reviewed for clarity by
two native speakers (one kidney patient, one clinician).
The complete questionnaires are provided as (S2 File).
Recruitment of participants
Kidney patients. We recruited patients from Austria, Dutch-speaking Belgium, Spain, the
Netherlands, and the United Kingdom via national patient organizations, or–in the absence of
such an organization in Belgium—via nephrologists in five dialysis centres. Patients were eligi-
ble to participate if they (1) had been on haemodialysis for at least 91 consecutive days, and (2)
had an e-mail address, which they accessed regularly. Finally, 101 patients consented and
received an invitation for phase 1. For phase 2, we invited all patients who completed phase 1.
Clinicians. For phase 1 we approached various clinician groups involved in vascular access
care via the European Renal Association–European Dialysis and Transplant Association, Euro-
pean Society of Vascular Surgery, Vascular Access Society (VAS), VAS of Britain and Ireland,
and national professional networks for renal nurses in Dutch-speaking Belgium, Italy, Spain,
and the Netherlands. Dissemination strategies varied between societies, including undirected
e-mail blasts to all members, direct mailings, and a link in electronic newsletters or on societies’
website. For phase 2, we invited 764 clinicians from phase 1 who indicated their interest in fur-
ther participation.
Data collection and analysis
We collected data in SurveyMonkey (www.surveymonkey.com) between February and October
2014. For both surveys, participants received up to two reminders after three and six weeks.
We summarized data using descriptive statistics as appropriate. In all analyses, we distin-
guished patients, nephrologists, nurses, and surgeons/radiologists as separate respondent
groups.
We calculated standardized ratings (ratingstd) for each individual before calculating mean
ratings within each respondent group to account for the phenomenon that different people
tend to use different ranges of a rating scale [20]. Per topic, we subtracted a respondent's mean
rating across all topics from the original rating, and divided the result by the respondent's stan-
dard deviation [23]. Using each respondent group’s mean ratingstd, we then compared priori-
ties between patients and each clinician group by performing two-sample t-tests per topic. To
correct for multiple testing, we considered a p-value< 0.01 to indicate a statistically significant
difference in priority rating.
For ease of interpretation we back-transformed the ratingstd to the original scale for report-
ing priority ratings in the text and main tables (referred to as adjusted ratings, ratingadj), as fol-
lows. We calculated the overall mean and standard deviation, using the original ratings across
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all topics and respondents. Subsequently, we multiplied each respondent's standardized ratings
by the overall standard deviation, and added the overall mean.
We performed all analyses using IBM SPSS Statistics for Windows version 20.0.0.1.
Ethical approval
The Research Ethics Committee of Ghent University Hospital (Ghent, Belgium) approved the
study. The committees of the Academic Medical Center (Amsterdam, The Netherlands), Barts
Health NHS Trust (London, UK), Consorci General University Hospital (Valencia, Spain), and
Medical University of Vienna (Vienna, Austria) informed us that they did not deem formal
approval necessary.
Results
Participants
Table 1 displays all participants' characteristics.
Of the 101 consenting kidney patients who received an invitation for phase 1, 85 responded
(response rate [RR], 84%). The majority were 51 to 65 years of age, and female, had been on
haemodialysis for more than five years, and were receiving haemodialysis at the time of the
study; 76 (89%) had most experience with dialysis via a fistula or graft. The characteristics of
the 50 patients who completed the phase 2 survey (RR, 59%) were similar to those participating
in phase 1.
In total, 1021 clinicians from 92 countries completed the questionnaire in phase 1; our
method of distribution did not allow us to ascertain a response rate. The majority were aged 35
to 50 years, male, were practicing as a nephrologist, had over twenty years of clinical experi-
ence, and spent most of their time in direct patient care. Of the 764 clinicians invited for phase
2, 425 responded (RR, 56%), with similar characteristics to clinicians in phase 1.
Topic prioritization
In total, we included 43 782 original ratings, with an overall mean of 4.20 (standard deviation
[SD], 0.46). The mean ratingadj and priority ranking for all topics per respondent group (S3
File), as well as all individual survey responses (S4 File) are provided.
Kidney patients. The overall mean for patients across all original ratings was 4.18 (SD,
0.48). On 30 occasions (<1% of all ratings) sixteen different patients indicated to be unable to
rate at least one topic’s priority. Table 2 presents the ten topics to which patients assigned high-
est priority, with 'managing catheter thrombosis' occupying the top position. Overall, 'manag-
ing needle phobia' (mean ratingadj, 3.69; SD, 0.57), 'catheter insertion methods' (mean ratingadj,
3.82; SD, 0.52), and 'managing pain during cannulation' (mean ratingadj, 3.90; SD, 0.65)
received the lowest priority.
Clinicians. For nephrologists, nurses, and surgeons/radiologists, the overall mean original
ratings were 4.18 (SD, 0.44), 4.42 (SD, 0.38), and 3.99 (SD, 0.53), respectively. The following
four topics appeared in the top 10 priority ranking of all groups: ‘selection of vascular access
type’; ‘preservation of veins’; ‘management of fistula/graft stenosis’; and ‘management of cen-
tral vein obstruction’. Nephrologists and nurses assigned highest priority to ‘preventing cathe-
ter infections’ (mean (SD) ratingadj of 4.53 (0.27) and 4.49 (0.27), respectively). Surgeons/
radiologists ranked this topic 18th (mean ratingadj, 4.30; SD, 0.37), and gave top priority to
‘selection of vascular access type’ (mean ratingadj, 4.57; SD, 0.24). ‘Management of perigraft ser-
omas’ was at the bottom of the overall ranking for all clinician groups, with a mean (SD)
Priorities for Optimizing Decisions about Vascular access for Dialysis
PLOS ONE | DOI:10.1371/journal.pone.0128228 July 7, 2015 5 / 13
Table 1. Participants’ characteristics.a)
Characteristics Number (%)b)
Kidney patients (n = 85)
Country of residence
Austria 13 (15)
Belgium 20 (24)
Spain 12 (14)
The Netherlands 25 (29)
United Kingdom 15 (18)
Age (years)
< 35 10 (12)
35 to 50 23 (27)
51 to 65 35 (41)
> 65 17 (20)
Male 29 (34)
Currently on haemodialysis 74 (87)
Total time on haemodialysis (years)
< 1 9 (11)
1 or 2 22 (26)
3 to 5 17 (20)
> 5 37 (44)
Pre-dominantly dialyzed via. . . .
. . . an arteriovenous ﬁstula or graft 76 (89)
. . .a tunneled catheter 9 (11)
Clinicians (n = 1021)
Country of practice
Spain 116 (11)
Germany 95 (9)
Italy 88 (9)
United Kingdom 77 (8)
Belgium 65 (6)
Other 580 (57)
Age (years)
< 35 92 (9)
35 to 50 450 (44)
51 to 65 431 (42)
> 65 48 (5)
Male 654 (64)
Practising as a
Nephrologist 687 (67)
Nurse 194 (19)
Surgeon 126 (12)
Radiologist 14 (1)
Clinical experience (years)
< 5 79 (8)
5 to 10 153 (15)
11 to 20 311 (31)
> 20 478 (47)
Time spent in direct patient care (%)
(Continued)
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ratingadj of 3.54 (0.61), 3.53 (0.75) and 3.58 (0.55) for nephrologists, nurses, and surgeons/radi-
ologists, respectively.
Differences in priority ratings between patients and clinicians
Patients’ priorities differed significantly for thirteen topics when compared to nephrologists,
thirteen when compared to surgeons/radiologists, and for seven topics when compared to
nurses (supplement material). In general, patients assigned higher priority than clinicians to
topics regarding managing adverse effects of arteriovenous access and patient involvement in
care (compared to nephrologists), while giving lower priority to decisions around preparing for
access creation, the surgical procedure, and preventing poor fistula maturation. For 23 of 42
topics, priority ratings did not differ significantly between patients and any clinician group;
this included five of the ten top priority topics for patients (Table 2).
Differences in ratings between groups for patients’ high priority topics. Table 2 shows
that we found a statistically (borderline) significant difference for ten of 30 comparisons con-
cerning patients’ top priority topics; six stemmed from patients rating topics differently from
surgeons/radiologists. Patients assigned higher priority than clinicians to ‘managing fistula/
graft-related heart disease’ (compared to any clinician group); ‘catheter thrombosis’ and ‘pre-
venting perioperative fistula/graft infections’ (compared to surgeons/radiologists); and ‘preop-
erative assessment of vessels’ (compared to nurses). Patients assigned lower priority to
‘selection of vascular access type’ (compared to nephrologists and surgeons/radiologists), and
‘preoperative assessment of vessels’ and ‘selection of vascular access site’ (compared to sur-
geons/radiologists).
Differences in ratings between groups for clinicians’ high priority topics. Table 3 dis-
plays comparisons for the eight topics that were absent in the patient top 10, but appeared in
the top 10 priority ranking of one or more clinician group. Clinicians assigned a higher priority
rating than patients to ‘preservation of veins’ and ‘management of fistula/graft stenosis’ (all
groups); ‘timing of vascular access creation’ and ‘surgical techniques for fistula/graft creation’
(nephrologists and surgeons/radiologists).
For the remaining four topics in Table 3, we found no evidence for differing priority ratings.
Discussion
Summary of findings
In this study, we explored and compared kidney patients' and clinicians' perspective on what
decisions related to vascular access care deserved priority for coverage by an international
guideline. Selection of access type and site, as well as preventing access infections received high
priority across respondent groups. Patients generally assigned higher priority to decisions
regarding managing adverse effects of arteriovenous access and patient involvement in care,
Table 1. (Continued)
Characteristics Number (%)b)
< 25 46 (4)
25 to 50 130 (13)
51 to 75 334 (33)
> 75 511 (50)
a) Participants in phase 1
b) Percentages may not add up to 100% due to rounding off
doi:10.1371/journal.pone.0128228.t001
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while clinicians more often prioritized decisions around sustaining patients’ access options,
technical aspects of access creation, and optimizing fistula maturation and patency.
Top priorities for optimizing vascular access decision making
When taking into account both the patient and clinician perspective, the following four vascu-
lar access-related decisions emerged as most important: access type selection, access site
Table 2. Comparing priority ratings between kidney patients and clinicians for the ten topics to which patients assigned highest priority. Abbrevia-
tions: N, number of respondents who rated the importance of a topic; SD, standard deviation.
KIDNEY PATIENTS CLINICIANS
Nephrologists (N = 687) Nurses (N = 194) Surgeons & radiologists
(N = 140)
Topic Rank a) N Mean
adjusted
(SD)
rating
Rank a) Mean
adjusted
(SD)
rating
P-value b) Rank a) Mean
adjusted
(SD)
rating
P-value b) Rank a) Mean
adjusted
(SD)
rating
P-value b)
Catheter
thrombosis
1 9 4.47 (0.33) 14 4.33 (0.33) 0.25 11 4.33 (0.33) 0.24 28 4.12 (0.37) 0.011
Selection of
vascular
access type c)
2 85 4.39 (0.29) 2 4.49 (0.31) < 0.01 9 4.34 (0.37) 0.22 1 4.57 (0.24) < 0.001
Training
clinicians to
create/maintain
access
3 85 4.37 (0.41) 13 4.34 (0.34) 0.53 14 4.32 (0.34) 0.35 8 4.41 (0.36) 0.41
Catheter
infection
4 9 4.36 (0.19) 1 4.53 (0.27) 0.03 1 4.49 (0.27) 0.08 18 4.30 (0.37) 0.40
Fistula/graft
infection
6 76 4.35 (0.36) 4 4.40 (0.33) 0.26 3 4.41 (0.29) 0.21 16 4.31 (0.32) 0.36
Perioperative
ﬁstula/graft
infection
5 76 4.34 (0.34) 22 4.27 (0.41) 0.08 4 4.40 (0.33) 0.21 23 4.20 (0.46) < 0.01
Preoperative
assessment of
vessels
7 85 4.33 (0.40) 18 4.30 (0.38) 0.42 24 4.20 (0.41) 0.012 5 4.49 (0.34) < 0.01
Fistula/graft-
related heart
disease
8 71 4.33 (0.40) 29 4.11 (0.41) < 0.001 30 4.15 (0.37) < 0.01 35 3.99 (0.40) < 0.001
Selection of
vascular
access site
9 85 4.32 (0.36) 5 4.40 (0.35) 0.08 15 4.32 (0.36) 0.87 4 4.50 (0.27) < 0.001
Strategies to
organize
vascular
access care d)
10 85 4.31 (0.37) 21 4.28 (0.37) 0.45 16 4.31 (0.35) 0.87 6 4.42 (0.34) 0.04
a) Ranking based on mean (standard deviation) standardized ratings
b) Based on two sample t-test of mean standardized ratings between patients and clinician group. P-values of <0.01 indicate a disagreement on priorities
between patients and clinicians, with values between 0.010 and 0.014 being considered borderline signiﬁcant.
c) Topic includes subtopics such as choosing between ﬁstula, graft and tunneled catheter; clinical and social (contra-)indications for speciﬁc access types;
last resort access types
d) Topic includes subtopics such as who should create ﬁstulas; specialized vascular access centres; multidisciplinary vascular access teams; vascular
access coordinators; formalized care pathways
doi:10.1371/journal.pone.0128228.t002
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selection, preventing catheter infection, and preventing fistula/graft infection. These topics
should get top priority for the updated ERBP guideline. As part of an international harmoniza-
tion initiative among seven renal guideline bodies [24], ERBP intends to update the systematic
reviews underlying the Caring for Australasians with Renal Impairment (CARI) vascular access
guidelines [25–27]. Apart from informing the clinical side of the decision-making process, the
updated evidence synthesis will allow identification of persistent gaps in knowledge. Current
research collaboratives focus on improving fistula maturation and patency [28,29], and our
study confirms the relevance of these topics from the clinician perspective. However, based on
our findings, health policy makers should additionally consider encouraging initiatives aimed
at improving patient outcomes for any access type (not just fistulas), and development of more
advanced (statistical) research methods to address the risk of selection bias in non-randomized
studies comparing outcomes between access types [8].
In keeping with previous studies, our results highlight a strong patient preference regarding
access type and site, and the management of access infections [5,10,11,30,31]. To communicate
this, Van der Weijden et al. suggested that guidelines should mark these and other patient-pri-
ority topics as decisions requiring elicitation of patient preferences [14]. This preference
Table 3. Comparing priority ratings between kidney patients and clinicians for topics to which clinicians assigned high priority, but that were
absent in patients’ top 10. Abbreviations: N, number of respondents who rated the importance of a topic; SD, standard deviation
KIDNEY PATIENTS CLINICIANS
Nephrologists (N = 687) Nurses (N = 194) Surgeons & radiologists
(N = 140)
Topic N Rank a) Mean
adjusted
(SD)
rating
Rank a) Mean
adjusted
(SD)
rating
P-value b) Rank a) Mean
adjusted
(SD)
rating
P-value b) Rank a) Mean
adjusted
(SD)
rating
P-value b)
Preservation of
veins
84 18 4.24 (0.51) 3 4.45 (0.36) < 0.01 2 4.43 (0.33) < 0.01 2 4.56 (0.34) < 0.001
Central vein
obstruction
9 24 4.22 (0.26) 6 4.40 (0.31) 0.07 7 4.36 (0.29) 0.13 7 4.41 (0.32) 0.06
Fistula/graft
thrombosis
76 11 4.31 (0.34) 10 4.36 (0.34) 0.18 5 4.40 (0.27) 0.05 11 4.37 (0.35) 0.19
Fistula/graft
stenosis
76 20 4.24 (0.35) 9 4.37 (0.34) < 0.01 8 4.36 (0.29) < 0.01 10 4.38 (0.34) < 0.01
Surveillance of
ﬁstula/graft
(dys)function
76 14 4.26 (0.30) 12 4.34 (0.35) 0.06 10 4.33 (0.34) 0.12 12 4.33 (0.35) 0.14
Surgical
techniques for
ﬁstula/graft
creation
75 33 4.10 (0.43) 8 4.39 (0.35) < 0.001 21 4.24 (0.43) 0.02 3 4.54 (0.28) < 0.001
Timing of
vascular
access
creation
84 26 4.21 (0.39) 7 4.39 (0.35) < 0.001 22 4.24 (0.36) 0.50 9 4.38 (0.33) 0.013
Perioperative
ﬁstula/graft
thrombosis
75 12 4.30 (0.37) 20 4.29 (0.38) 0.71 6 4.37 (0.34) 0.18 21 4.26 (0.35) 0.41
a) Ranking based on mean (standard deviation) standardized ratings
b) Based on two sample t-test of mean standardized ratings between patients and clinician group. P-values of <0.01 indicate a disagreement on priorities
between patients and clinicians, with values between 0.010 and 0.014 being considered borderline signiﬁcant.
doi:10.1371/journal.pone.0128228.t003
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elicitation could be accommodated by extending guideline recommendations with information
on the patient perspective, or by developing a guideline-based patient decision aid covering
these topics [13,14,32]. Readily available qualitative research, such as the recent qualitative evi-
dence synthesis by Casey et al. [5], may serve as a point of departure.
Differing priorities between patients and clinicians
Clinicians assigned less priority than patients to decisions around managing adverse effects of
arteriovenous access (e.g., fistula/graft-related heart disease) and catheter thrombosis (only
surgeons/radiologists). These lower ratings may reflect the relatively low prevalence of such
complications in clinicians’ daily practice. Nephrologists also gave lower ratings to topics
regarding patient involvement in care, potentially indicating unawareness of patient involve-
ment’s potential to improve outcomes [33]. Others might not recognize the uncertainty around
optimal kidney patient involvement in vascular access decisions, or the persistent room for
improvement [5,9]. Future studies investigating nephrologists’ knowledge on and attitude
towards patient involvement will help to design interventions that foster collaborative vascular
access decision making [34].
In contrast, preservation of veins received lower priority from patients than from clinicians.
This implies that patients do not strongly prefer certain vein preservation strategies to others,
and that they would accept the strategy recommended by their doctor. At the same time, our
results suggest that clinicians would like a more robust evidence base for recommending how
to preserve veins for fistula creation, making this an important topic for guideline develop-
ment. Patients also gave relatively low priority to topics related to the surgical procedure of
arteriovenous access creation. Since we asked patient respondents to assume medical equipoise
between treatment options, one explanation for the lack of preference might be that they do
not expect choices around access surgery, such as selecting a particular vein for fistula creation
or choosing between a synthetic and an autologous graft, to directly affect their lives.
Strengths and limitations
To our knowledge, this is the first study to explore both clinician and kidney patient priorities
on all decisions along the vascular access care pathway. Previous studies exploring patients’
perspectives on vascular access [5,10,11,30,31] focused mainly on the choice of access type,
and/or did not allow prioritization of patient preference-sensitive decisions; none of them per-
mitted a direct comparison with clinicians’ priorities. Our international study sample together
with our quantitative approach and analysis strategy, enabled us to draw a detailed and robust
picture of priorities among the main stakeholders in vascular access care. This picture comple-
ments the results from a recent study in which Canadian clinicians, patients and caregivers
identified vascular access as one of the research priorities within the management of kidney
failure [35]. Furthermore, we suggest that collaborating with kidney patients in developing and
executing the survey contributed to successful patient involvement in the early stages of guide-
line development, which is advocated by broadly accepted guideline development standards
[36–38].
Our study population likely represented a selected sample of clinicians and kidney patients.
This limits the generalizability of our findings, particularly those regarding patient priorities.
Patient respondents had to be able and willing to participate, understand the information in
the survey, use a computer and email account, and be active in patient organizations. Since
patient characteristics, such as higher educational attainment and better self-reported health,
potentially increase patients’ desire to be involved in treatment selection [39], this might have
resulted in our overestimating the strength of patients’ preferences for some decisions.
Priorities for Optimizing Decisions about Vascular access for Dialysis
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Selection bias may also explain the low number of patients with a permanent catheter in our
sample. This decreased the reliability of patient ratings for the seven catheter-related topics,
and thus the probability of finding differences with clinicians' ratings. Still, the patient ranks
were largely comparable to those for similar fistula-related topics. Lastly, kidney patients may
be more familiar with common treatments, for example those for managing prevalent compli-
cations. Having personal experience with particular treatments potentially affects whether one
prefers those treatments to others, with preference strength either increasing or decreasing,
depending on the experience itself. Since patients did not report on previous experiences with
vascular access care, we were unable to assess how this influenced our findings.
In conclusion, this study provides pointers for optimizing a collaborative decision-making
process around vascular access for haemodialysis. In addition to identifying the most pressing
knowledge gaps in access care, the findings contribute to developing guidelines that could ulti-
mately improve healthcare professionals’ understanding of when and how to involve kidney
patients in decisions on the vascular access care pathway.
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